股票代码：******

Research Platforms:

To continuously enhance corporate innovation, develop new products, optimize the industrial structure, and strengthen core teams’ management and technological innovation capabilities, the company integrates resources and refines functions to build R&D platforms such as the Jiangxi Provincial Laboratory Animal Center, the Provincial Enterprise Technology Center, the Shenzhen R&D Center, and the “Haizhi Plan” research workstation. Our innovation functions continue to expand; with ongoing platform build-out and R&D, we have improved infrastructure, been approved as a Jiangxi Postdoctoral Innovation and Practice Base, and formally established a post‑doctoral research platform.

Established Jiangsheng (Shenzhen) Biotech R&D Center Co., Ltd. in Shenzhen and put it into operation; launched an international immune-cell R&D platform and implemented incubation of new products and technologies.

2019

Approved by provincial talent authorities and the Department of Human Resources and Social Security to establish the Jiangxi Biology R&D Center and run innovation labs; awarded the title of Jiangxi Province Specialized ‘‘Little Giant’’ Enterprise.

2022

Awarded the title of High tech Enterprise by the Department of Science and Technology of Jiangxi Province, the Department of Finance of Jiangxi Province, and the Jiangxi Provincial Taxation Bureau of the State Administration of Taxation

2024

2015

Established an Enterprise Technology Center and was jointly recognized by the Provincial Department of Industry and Information Technology, Provincial Department of Finance, Provincial Local Taxation Bureau, and Provincial State Taxation Bureau as a “Provincial Enterprise Technology Center.”

2020

Applied to establish the Ji’an “Haizhi Plan” workstation at Jiangxi Institute of Biological Products Inc., serving as a platform for introducing overseas talent.

2023

Approved for the Jiangxi Provincial Engineering Research Center for Biological
Immunotherapy Antibody Drugs; Jiangxi “Haizhi Plan” workstation; and designated a Jiangxi “Specialized, Refined, and Innovative” Small and Medium-sized Enterprise.

Jiangxi ‘‘Specialized, Refined, and Innovative’’ Small and Medium-sized Enterprise

Jiangxi Provincial Postdoctoral Innovation and Practice Base

Provincial Enterprise Technology Center

Jiangxi Haizhi Plan Workstation

Jiangxi Provincial Engineering Research Center for Biological Immune Antibody Drugs

SUSTech & Jiangxi Biology Immunology Research Laboratory

R&D Team:

R&D Team: We have a research team of 44 members holding master’s and doctoral degrees, with expertise in pharmacology, biotechnology, health management, and animal immunology—providing strong technical support for our current innovation and growth.

Talent Assurance:

Established long‑term talent introduction mechanisms with Nanchang University, Jiangxi University of Chinese Medicine, and Jinggangshan University to continually supply high‑quality management, technical, and R&D talent.

Leveraging the Ji’an “Haizhi Plan” workstation of Jiangxi Institute of Biological Products Inc. to introduce Dr. Clifton Shen from UCLA David Geffen School of Medicine for joint product R&D.

Brought in a Canadian expert team to collaborate on related product research.

Working with Nanchang University’s post‑doctoral mobile station to jointly establish an enterprise post‑doctoral workstation for talent cultivation and project R&D.